Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (64)

1

Probable Interaction Between Warfarin and the Combination of Remdesivir With Dexamethasone for Coronavirus Disease 2019 (COVID-19) Treatment : A 2 Case Report

enthalten in: Journal of pharmacy practice | 2022

von Landayan, R. | Saint-Felix, S. | Williams, A.

2

An EUA for anakinra (Kineret) for COVID-19

enthalten in: The Medical letter on drugs and therapeutics | 2022

3

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants

enthalten in: Infectious disease reports | 2022

von Fujimoto, K. | Mutsuo, S. | Yasuda, Y. | +4

4

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults : A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

enthalten in: Annals of internal medicine | 2022

von Potter, G. | Bonnett, T. | Rubenstein, K. | +41

5

Profile and outcome of COVID-19 patients treated at a secondary hospital in Central India during the second wave of the pandemic

enthalten in: Journal of family medicine and primary care | 2022

von Deepti, M. | Paul, A. | Timothy, F. | +3

6

No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients : a retrospective observational study

enthalten in: Infectious diseases (London, England) | 2022

von Sourander, B. | Andersson, L. | Brink, M. | +7

7

Permanent Pacemaker Placement Secondary to Remdesivir Induced Bradycardia : A Case Report

enthalten in: Cureus | 2022

von Khan, S. | Mustafa, A. | Elhosseiny, S. | +2

8

Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients : common oversights and streamlining the development of clinically effective therapeutics

enthalten in: Expert opinion on investigational drugs | 2022

von Battaglini, D. | Cruz, F. | Robba, C. | +2

9

In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival

enthalten in: Annals of internal medicine | 2022

von Tran, A. | Rochwerg, B.

CommentOn: Lancet Respir Med. 2022 Sep;10(9):888-899. - PMID 35617986

10

In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir

enthalten in: Chemico-biological interactions | 2022

von Zhang, Q. | Melchert, P. | Markowitz, J.

1
2
3
4
5
6
7
Nächster »
[7]